Astec LifeSciences Limited
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
Key metrics
Price as of 2026-07-17
Stock price
₹690.75
Market cap
1,539 Cr
P/B
3.94
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 143 Cr | 254 Cr | 304 Cr | 458 Cr | 69 Cr | 168 Cr | 94 Cr | 120 Cr | 91 Cr | 74 Cr | 125 Cr | 159 Cr |
| Operating expenses (approx.) | 138 Cr | 251 Cr | 319 Cr | 458 Cr | 115 Cr | 231 Cr | 100 Cr | 113 Cr | 102 Cr | 79 Cr | 123 Cr | 147 Cr |
| EBITDA | 5 Cr | 2 Cr | -15 Cr | -0.27 Cr | -45 Cr | -63 Cr | -6 Cr | 6 Cr | -10 Cr | -6 Cr | 2 Cr | 12 Cr |
| OPM % | 3.4% | 0.9% | -4.9% | -0.1% | -65.3% | -37.6% | -6.1% | 5.3% | -11.5% | -7.6% | 1.5% | 7.4% |
| Other income | 2 Cr | 3 Cr | 4 Cr | 6 Cr | 0.92 Cr | 3 Cr | 2 Cr | 0.79 Cr | 0.51 Cr | 1 Cr | 0.82 Cr | 3 Cr |
| Interest | 6 Cr | 12 Cr | 19 Cr | 25 Cr | 7 Cr | 16 Cr | 10 Cr | 10 Cr | 11 Cr | 8 Cr | 7 Cr | 8 Cr |
| Depreciation | 9 Cr | 19 Cr | 27 Cr | 36 Cr | 9 Cr | 21 Cr | 11 Cr | 12 Cr | 11 Cr | 10 Cr | 11 Cr | 12 Cr |
| Profit before tax | -11 Cr | -29 Cr | -61 Cr | -62 Cr | -62 Cr | -100 Cr | -25 Cr | -16 Cr | -33 Cr | -24 Cr | -16 Cr | -8 Cr |
| Tax % | 25.6% | 24.5% | 24.5% | 24.1% | 35.6% | 21.9% | -60.5% | -2.7% | -0.0% | -0.0% | -0.1% | 1.9% |
| Net profit | -8 Cr | -22 Cr | -46 Cr | -47 Cr | -40 Cr | -78 Cr | -40 Cr | -16 Cr | -33 Cr | -24 Cr | -16 Cr | -8 Cr |
| EPS (₹) | ₹-4.18 | ₹-11.03 | ₹-23.44 | ₹-23.93 | ₹-20.26 | ₹-39.92 | ₹-20.59 | ₹-8.20 | ₹-16.85 | ₹-11.35 | ₹7.04 | ₹-3.48 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 431 Cr | 523 Cr | 555 Cr | 677 Cr | 628 Cr | 458 Cr | 381 Cr | 448 Cr | Sign in for TTM |
| Operating expenses (approx.) | 343 Cr | 425 Cr | 435 Cr | 512 Cr | 552 Cr | 464 Cr | 442 Cr | 450 Cr | Sign in for TTM |
| EBITDA | 88 Cr | 97 Cr | 119 Cr | 165 Cr | 76 Cr | -6 Cr | -61 Cr | -2 Cr | Sign in for TTM |
| OPM % | 20.3% | 18.6% | 21.5% | 24.3% | 12.1% | -1.3% | -15.9% | -0.3% | Sign in for TTM |
| Other income | 11 Cr | 12 Cr | 8 Cr | 10 Cr | 13 Cr | 6 Cr | 6 Cr | 5 Cr | Sign in for TTM |
| Interest | 12 Cr | 13 Cr | 5 Cr | 9 Cr | 21 Cr | 25 Cr | 37 Cr | 35 Cr | Sign in for TTM |
| Depreciation | 19 Cr | 23 Cr | 26 Cr | 34 Cr | 34 Cr | 36 Cr | 44 Cr | 45 Cr | Sign in for TTM |
| Profit before tax | 56 Cr | 61 Cr | 89 Cr | 121 Cr | 35 Cr | -62 Cr | -141 Cr | -81 Cr | Sign in for TTM |
| Tax % | 36.0% | 22.5% | 26.9% | 25.8% | 26.8% | 24.1% | 4.5% | 0.2% | Sign in for TTM |
| Net profit | 36 Cr | 48 Cr | 65 Cr | 90 Cr | 26 Cr | -47 Cr | -135 Cr | -81 Cr | Sign in for TTM |
| EPS (₹) | ₹18.28 | ₹24.29 | ₹33.23 | ₹45.87 | ₹13.04 | ₹-23.93 | ₹-68.71 | ₹-37.79 | Sign in for TTM |
| Dividend payout % | — | — | — | 3.3% | 11.5% | — | — | — | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 20 Cr | 22 Cr |
| Reserves | 183 Cr | 227 Cr | 290 Cr | 377 Cr | 400 Cr | 350 Cr | 215 Cr | 368 Cr |
| Borrowings | 176 Cr | 99 Cr | 187 Cr | 279 Cr | 341 Cr | 494 Cr | 275 Cr | 399 Cr |
| Other liabilities | 83 Cr | 227 Cr | 182 Cr | 221 Cr | 219 Cr | 112 Cr | 372 Cr | 152 Cr |
| Total liabilities | 461 Cr | 572 Cr | 678 Cr | 897 Cr | 979 Cr | 975 Cr | 881 Cr | 942 Cr |
| Fixed assets (net) | 165 Cr | 192 Cr | 212 Cr | 338 Cr | 287 Cr | 353 Cr | 497 Cr | 424 Cr |
| CWIP | 19 Cr | 22 Cr | 112 Cr | 14 Cr | 112 Cr | 148 Cr | 0.13 Cr | 0.20 Cr |
| Investments | 0.0053 Cr | 0.0053 Cr | 0.0053 Cr | 0.43 Cr | 0.0053 Cr | 0.0053 Cr | 0.0053 Cr | 0.0053 Cr |
| Other assets | 251 Cr | 364 Cr | 332 Cr | 516 Cr | 499 Cr | 399 Cr | 344 Cr | 446 Cr |
| Total assets | 461 Cr | 572 Cr | 678 Cr | 897 Cr | 979 Cr | 975 Cr | 881 Cr | 942 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 24 Cr | 75 Cr | 10 Cr | -8 Cr | -81 Cr |
| Cash from investing | — | — | — | -104 Cr | -113 Cr | -135 Cr | -15 Cr | -4 Cr |
| Cash from financing | — | — | — | 80 Cr | 38 Cr | 125 Cr | 24 Cr | 94 Cr |
| Net cash flow | — | — | — | 0.22 Cr | -0.08 Cr | -0.0019 Cr | 0.10 Cr | 9 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -80 Cr | -43 Cr | -125 Cr | -30 Cr | -86 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 33.7% | 30.0% | 30.3% | 32.8% | 5.6% | -4.9% | -20.5% | -5.9% |
| ROE % | 17.6% | 19.3% | 21.0% | 22.7% | 6.1% | -12.7% | -57.3% | -20.7% |
| Debtor days | 103 | 112 | 123 | 147 | 90 | 135 | — | — |
| Inventory days | 115 | 133 | 112 | 153 | 233 | 224 | 234 | 186 |
| Days payable | 79 | 222 | 133 | 156 | 140 | 102 | — | — |
| Cash conversion cycle | 139 | 23 | 102 | 145 | 183 | 257 | 234 | 186 |
| Debt / equity | 0.87 | 0.40 | 0.61 | 0.01 | 0.81 | 1.34 | 1.17 | 1.02 |
| Current ratio | 1.01 | 1.05 | 1.03 | 1.05 | 0.95 | 1.00 | 0.93 | 0.89 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 4.47 | — | — | — |
Compare with peers
Loading peers…